Frank A. Sinicrope
FACP, Mayo Clinic and Mayo Cancer Center
200 1st St SW
Rochester
Name/email consistency: high
- Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy Trials. Sinicrope, F.A., Foster, N.R., Yoon, H.H., Smyrk, T.C., Kim, G.P., Allegra, C.J., Yothers, G., Nikcevich, D.A., Sargent, D.J. J. Clin. Oncol. (2012)
- DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-Fluorouracil-based adjuvant therapy. Sinicrope, F.A., Foster, N.R., Thibodeau, S.N., Marsoni, S., Monges, G., Labianca, R., Yothers, G., Allegra, C., Moore, M.J., Gallinger, S., Sargent, D.J. J. Natl. Cancer Inst. (2011)
- The role of autophagy in cancer: therapeutic implications. Yang, Z.J., Chee, C.E., Huang, S., Sinicrope, F.A. Mol. Cancer Ther. (2011)
- Evaluation of Difluoromethylornithine for the Chemoprevention of Barrett's Esophagus and Mucosal Dysplasia. Sinicrope, F.A., Broaddus, R., Joshi, N., Gerner, E., Half, E., Kirsch, I., Lewin, J., Morlan, B., Hong, W.K. Cancer. Prev. Res. (Phila) (2011)
- Obesity is an independent prognostic variable in colon cancer survivors. Sinicrope, F.A., Foster, N.R., Sargent, D.J., O'Connell, M.J., Rankin, C. Clin. Cancer Res. (2010)
- DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer. Sinicrope, F.A. Nat. Rev. Clin. Oncol (2010)
- Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Sinicrope, F.A., Rego, R.L., Ansell, S.M., Knutson, K.L., Foster, N.R., Sargent, D.J. Gastroenterology (2009)
- Clinical implications of microsatellite instability in sporadic colon cancers. Sinicrope, F.A., Sargent, D.J. Curr. Opin. Oncol (2009)
- Prognostic impact of bim, puma, and noxa expression in human colon carcinomas. Sinicrope, F.A., Rego, R.L., Okumura, K., Foster, N.R., O'Connell, M.J., Sargent, D.J., Windschitl, H.E. Clin. Cancer Res. (2008)
- Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers. Sinicrope, F.A., Rego, R.L., Foster, N.R., Thibodeau, S.N., Alberts, S.R., Windschitl, H.E., Sargent, D.J. Clin. Cancer Res. (2008)
- Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability. Sinicrope, F.A., Rego, R.L., Garrity-Park, M.M., Foster, N.R., Sargent, D.J., Goldberg, R.M., Wiesenfeld, M., Witzig, T.E., Thibodeau, S.N., Burgart, L.J. Int. J. Cancer (2007)
- Thymidylate synthase expression in colon carcinomas with microsatellite instability. Sinicrope, F.A., Rego, R.L., Halling, K.C., Foster, N.R., Sargent, D.J., La Plant, B., French, A.J., Allegra, C.J., Laurie, J.A., Goldberg, R.M., Witzig, T.E., Thibodeau, S.N. Clin. Cancer Res. (2006)
- Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Sinicrope, F.A., Rego, R.L., Halling, K.C., Foster, N., Sargent, D.J., La Plant, B., French, A.J., Laurie, J.A., Goldberg, R.M., Thibodeau, S.N., Witzig, T.E. Gastroenterology (2006)
- Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2. Sinicrope, F.A., Penington, R.C. Mol. Cancer Ther. (2005)
- Is ursodeoxycholic acid effective for the prevention of colorectal adenoma recurrence?. Sinicrope, F. Nature Clinical Practice. Gastroenterology & Hepatology (2005)
- Role of cyclooxygenase-2 in colorectal cancer. Sinicrope, F.A., Gill, S. Cancer Metastasis Rev. (2004)
- Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Sinicrope, F.A., Half, E., Morris, J.S., Lynch, P.M., Morrow, J.D., Levin, B., Hawk, E.T., Cohen, D.S., Ayers, G.D., Stephens, L.C. Cancer Epidemiol. Biomarkers Prev. (2004)









